FindTrial
Sign In

STUDY TO EVALUATE COMBINED EFFECT OF NYGRODADI CHURNA AND ASNADI KASHAYA IN MADHUMEHA( TYPE 2 DIABETES)

A THREE ARM CLINICAL STUDY TO EVALUATE THE INDIVIDUAL AND COMBINED EFFECT OF NYGRODADI CHURNA AND ASANADI KASHAYA IN THE MANAGEMENT OF MADHUMEHA VIS-A-VIS TYPE 2 DIABETES MELLITUS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/093957
Enrollment
60
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Ramakrishna ayurvedic medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: fasting blood glucose level more than 110-180 postprandial blood sugar level more then 140-250 patient ready to sign informed consent

Exclusion criteria

Exclusion criteria: patient with insulin dependent diabetes mellitus patient with complications of madhumeha or t2dm diabeties with endocronities drug or chemical induced dm genetic symptoms including dm suffering sever systemic diseases patients with type 1 dm blood sugar fasting less greater than 180 post prandial sugar level more than 250

Design outcomes

Primary

MeasureTime frame
to evalate combined action of drug nygrodadhi churna and asanadi kashya in madhumeha and t2dmTimepoint: evaluation is done on 0th day 15 day and 30th day—

Secondary

MeasureTime frame
to evaluate induvidal action of nygrodadhi churna and asanadhi kashayaTimepoint: evaluation is done on 0th day 15th day 30th day—

Countries

India

Contacts

Public ContactDr Archana C P

Ramakrishna ayuvedic medical college

aayurvedalaya@gmail.com9900063059

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026